ChEMBL ID: CHEMBL2109621
Mechanism of action: Integrin alpha-V/beta-1 inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to ABITUZUMAB